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Abstract
Background: Genome-wide association studies provide important insights to the genetic component of disease
risks. However, an existing challenge is how to incorporate collective effects of interactions beyond the level of
independent single nucleotide polymorphism (SNP) tests. While methods considering each SNP pair separately have
provided insights, a large portion of expected heritability may reside in higher-order interaction effects.
Results: We describe an inference approach (discrete discriminant analysis; DDA) designed to probe collective
interactions while treating both genotypes and phenotypes as random variables. The genotype distributions in case
and control groups are modeled separately based on empirical allele frequency and covariance data, whose
differences yield disease risk parameters. We compared pairwise tests and collective inference methods, the latter
based both on DDA and logistic regression. Analyses using simulated data demonstrated that significantly higher
sensitivity and specificity can be achieved with collective inference in comparison to pairwise tests, and with DDA in
comparison to logistic regression. Using age-related macular degeneration (AMD) data, we demonstrated two
possible applications of DDA. In the first application, a genome-wide SNP set is reduced into a small number (∼ 100)
of variants via filtering and SNP pairs with significant interactions are identified. We found that interactions between
SNPs with highest AMD association were epigenetically active in the liver, adipocytes, and mesenchymal stem cells. In
the other application, multiple groups of SNPs were formed from the genome-wide data and their relative strengths
of association were compared using cross-validation. This analysis allowed us to discover novel collections of loci for
which interactions between SNPs play significant roles in their disease association. In particular, we considered
pathway-based groups of SNPs containing up to ∼ 10,000 variants in each group. In addition to pathways related to
complement activation, our collective inference pointed to pathway groups involved in phospholipid synthesis,
oxidative stress, and apoptosis, consistent with the AMD pathogenesis mechanism where the dysfunction of retinal
pigment epithelium cells plays central roles.
Conclusions: The simultaneous inference of collective interaction effects within a set of SNPs has the potential to
reveal novel aspects of disease association.
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Background
A key focus of modern genetic research is the relationship
between genomic variations and phenotypes, including
susceptibilities to common diseases [1]. Recent advances
in genome-wide association studies (GWAS) have greatly
enhanced our understanding of such genotype-phenotype
relationships [2–9]. In many cases, however, a large por-
tion of the expected heritability information remains to be
discovered. It has recently been shown that meta-analyses
involving increasingly large sample sizes can yield many
additional loci of statistical significance [10, 11]. Another
potential source of such ‘missing heritability’ is the contri-
bution of rare variants not detected by population-based
genotyping platforms. Recent studies based on exome and
whole-genome sequencing data combined with statisti-
cal tests including burden tests [12], C-alpha test [13],
and sequence kernel association test [14] are beginning
to address such possibilities. It is also expected, however,
that the limitation of independent single nucleotide poly-
morphism (SNP) analyses, where each locus is considered
separately to evaluate its association with disease using
trend tests or logistic regression models [15], and possible
effects of epistasis also contribute to the limited degree of
biological effects uncovered so far.
Many studies have addressed the issue of incorporat-
ing such inter-variant interactions, or epistasis, in GWAS
[16, 17]. Main approaches include machine-learning tech-
niques [18–23], entropy-based methods [24], principal
component analyses [25–27], and the genome-wide inter-
action analysis considering all distinct pairs of SNPs
[28–31]. One useful strategy, in particular, is to extend
parametric models to many SNPs that have been suit-
ably selected, and inferring interaction effects under a
multivariate statistical setting. Previous works within this
framework include those based on lasso-penalized logis-
tic regression [32, 33]. Under the setting of inference on
many interacting SNPs, the dimensionality of the underly-
ing model is of the order ofm2, wherem is the number of
SNPs that are considered simultaneously, withm = 1 and
2 corresponding to the independent-SNP and pairwise
tests, respectively. To prevent model overfitting, high-
dimensional inference with limited sample sizes requires
regularization, whose values can be determined by cross-
validation. Ayers and Cordell performed a comprehensive
study of the performance of different penalizer choices on
noninteracting SNP inferences [34].
This class of methods within the context of GWAS so
far exclusively used logistic (or linear) regression analyses
for case-control (or quantitative phenotype) data, which
parallels their similarly widespread adoption in the gen-
eral statistical learning literature. One may note, however,
that the actual training data sets in GWAS are collected
from case and control populations with distinct genotype
distributions. The likelihood of the data to be maximized
for inference is given by the joint probability of both
genotypes (predictor variables) and phenotypes (response
variables). In (logistic) regression, this joint probability is
replaced by the probability of phenotypes conditional to
genotypes, and the marginal probability of genotypes is
assumed to be uniform.
In statistical learning, discriminant analysis is another
widely used option for classifying continuous random
variables in addition to logistic regression [35–37]. This
class of inference methods offers alternative approaches
that fully model the joint distribution of predictor and
response variables (Section 4.4.5 in Hastie et al. [37])
at the expense of assuming specific predictor distribu-
tions (usually multivariate normal distributions). It has
been estimated that, for continuous variables, the accu-
racy of logistic regression models can be lower by ∼ 30 %
than that of discriminant analyses for a given sample
size [35, 37].
Genotype distributions within populations from which
GWAS samples are collected are also far from uniform,
and it is of interest to examine the utility of discriminant
analysis-type approaches to disease association inference
under high-dimensional settings, which is the main focus
of this paper. The standard discriminant analysis, how-
ever, is applicable only for continuous variable predictors.
A related approach, the discriminant analysis of principal
components by Jombart et al. [38], applies discriminant
analysis to principal components (continuous variables)
of allele frequencies for unsupervised learning of popula-
tion structures. We report here, as a major innovation, an
adaptation of discriminant analysis to the case of discrete
genotype data (discrete discriminant analysis; DDA).
Our inference includes the causal effects of both
marginal single-SNP terms and their interactions. These
effects are estimated simultaneously, rather than sepa-
rately as in independent-SNP and pairwise analyses. We
refer to such combined effects of single-SNP and interac-
tion contributions as the collective effects of disease asso-
ciation. This level of description is analogous to that of the
logistic regression inference performed by Wu et al. [33]
in terms of the nature of SNP effects included in the mod-
eling. Association studies have two distinct but related
goals: inference and prediction. In inference (also known
as feature selection), one aims to identify a subset of SNPs
that are deemed to be causal, while in prediction, the goal
is to apply the trainedmodel and predict the disease status
of unknown samples. Independent-SNP analyses widely
performed in GWAS, either based on trend tests or logis-
tic regression models with marginal SNP effects only, are
mainly geared toward inference. In contrast, the penalized
logistic regression including collective effects [33] is more
suited to prediction, because the disease risk parameters
are optimized directly via maximum likelihood without
reference to population structures.
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Our method offers a comprehensive approach achiev-
ing both inference and prediction by training models
to genotype distributions of case and control groups
separately under penalizers. The regularization using
cross-validation optimizes prediction capability, while for
inference, we derived effective p-values of the over-
all single-SNP (we use this terminology to refer to the
contribution each locus makes by itself to the over-
all association, usually in the presence of interactions)
and interaction effects using likelihood ratio tests. To
our knowledge, the performance comparison of interac-
tion effect detection between pairwise tests and (logistic
regression) collective inference has not been reported yet.
Our results based on simulated data indicate that collec-
tive inference provides far higher sensitivity for interac-
tions than pairwise tests. Compared to penalized logistic
regression, DDA yielded further advantages in sensitivity
and specificity.
Our current collective inference implementation allows
for the maximum likelihood inference of systems contain-
ing up to ∼ 104 SNPs. However, evaluating interaction p-
values of SNP pairs by permutation resampling increases
the computational cost by orders of magnitude, limiting
the number of SNPs that can be considered in practice.
In addition, the requirement for pre-selection of vari-
ants based, for example, on independent-SNP p-values,
limits the possibility for discovering novel loci whose
effects are significant only when interactions are taken
into account. To deal more directly with genome-wide
data in an unbiased fashion, we describe a second mode
of DDA application where ∼ 106 SNPs are grouped into
(∼ 103 ormore) subsets based on phenotype-independent
criteria (e.g., biological pathways), the collective inference
is applied to each subset, and their relative importance in
disease association is evaluated based on cross-validation
prediction score. This protocol significantly expands the
power of SNP-based pathway analysis beyond existing
enrichment-based methodologies [39] by allowing for the
incorporation of collective interaction effects within each
pathway.
By applying our algorithm to the disease data of age-
related macular degeneration (AMD) [40, 41], we demon-
strate that the enhanced ability to account for interaction
effects can translate into novel biological findings. AMD
is a progressive degenerative disease affecting individ-
uals in old age, characterized by the accumulation of
deposits (drusen) in the retina or choroidal neovas-
cularization, which can lead to vision loss. Genome-
wide studies of AMD constitute one of the earliest and
most successful applications of GWAS [2, 3, 40–43],
where strong associations were detected and later val-
idated at variants including those near complement
pathway genes CFH, C2, and C3, in addition to
the ARMS2/HTRA1 loci. However, direct molecular
mechanisms tying these associated loci into disease
pathogenesis remain unclear. Using AMD case-control
data, we first analyzed detailed interaction patterns within
SNPs selected based on independent-SNP association
strengths. These interactions were enriched in loci epi-
genetically active in tissues including adipocytes, mes-
enchymal stem cells, and the liver. We then applied DDA
to pathway-based groups formed from genome-wide data
and found high association with pathways involved in
phospholipid synthesis, cellular stress response, apopto-
sis, and complement activation.
Results and discussion
Our algorithm (DDA) extends the discriminant analysis to
discrete genotype data. Its overall steps are summarized
in Fig. 1 and described in Methods (see Additional file 1:
Text S1 for more in-depth details).
Independent SNPs
When interactions between the loci are turned off, DDA
can be solved analytically (see Additional file 1: Text S1),
whereas logistic regression is always numerical. We first
compared this special case of DDA and logistic regres-
sion without interaction and found the odds ratio and
power to be identical for all conditions for binary mod-
els (Additional file 2: Figure S1), which implies that the
effect of marginal genotype distributions ignored in logis-
tic regression is negligible for a single non-interacting
locus. However, since DDA can yield p-values of each
locus without numerical optimization, it leads to con-
siderable computational speed-up even when interactions
are not included.
Simulation
We compared pairwise tests, logistic regression, and DDA
in similarly well-controlled but high-dimensional con-
ditions in which collective effects can play important
roles. In the following, unless otherwise specified, logis-
tic regression refers to the collective inference includ-
ing both marginal and interaction terms and a penalizer
(see Methods). We used simulated data that faithfully
reflected prescribed genotype distributions of given sam-
ple sizes. A genotype distribution for a binary model
with m loci has m single-SNP and m(m − 1)/2 interac-
tion parameters. We specified these parameters randomly
from normal distributions, generated genotype samples
of size n based on these distributions, performed pair-
wise marginal inference, logistic regression, and DDA,
and compared inferred parameters with the true val-
ues (Additional file 3: Figure S2 shows examples for the
dominant and genotypic models). Our simulated data
include linkage disequilibrium (LD): if one approximates
the genotype distribution as a continuous-variable normal
distribution, the correlation within a single group (case or
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Fig. 1 Discrete discriminant analysis algorithm. Empirical characteristics (allele frequency and correlation) of case (y = 1) and control (y = 0) data
are used to fit their genotype distributions with parameters h(y)i and J
(y)
ij , each roughly determining the position and width of the distribution.
Disease risk parameters are given by their differences, whereas the likelihood ratio (LR) statistic q is obtained from the difference between the sum of
two contributions and the corresponding pooled value
control) would be proportional to the matrix inverse of
interaction parameters specified, and the overall r2 would
correspond to the sample size-weighted average over case
and control groups.
For a given sample, we first determined the optimal
penalizer (λ) value by cross-validation. With increasing
λ, the mean square error and the area under the curve
(AUC) of the receiver operating characteristics generally
showed a minimum and maximum, respectively, at λ∗
(Additional file 4: Figure S3). The value of λ∗ decreased
as the sample size n increased. This trend implies that for
small n, an aggressive regularization is needed (large λ∗) to
minimize overfitting, while for larger n, more interaction
terms are inferred with sufficient significance, leading to
smaller λ∗.
Accuracy of inference We compared results of pairwise
marginal tests using PLINK [44], logistic regression, and
three versions of DDA [exact enumeration; EE, pseudo-
likelihood; PL, and mean field; MF (see Methods)] in two
different simulation settings. In the first case (Fig. 2a–b),
we used m = 10 SNPs with parameters chosen such
that all sites had relatively large and strong single-SNP
and interaction effects. We used the dominant model in
these simulations in order to facilitate sampling, which
requires exhaustive enumeration of all genotypes (2m and
3m for binary and genotypic models, respectively). Pair-
wise tests derive odds ratios and p-values for each SNP
pair separately, and the logarithm of the interaction odds
ratio corresponds to the interaction parameter. The mean
square error of pairwise inference decreased slightly from
sample size n = 102 to 103 but showed little improvement
for larger sample sizes. Outcomes from logistic regression
and DDA exhibited AUC values (maximized with respect
to λ for each sample) increasing with n for n ≤ 103.
The AUCs from logistic regression were slightly lower for
n ≤ 103 than DDA and comparable in larger sample sizes.
The mean square error of logistic regression and DDA
steadily decreased (approximately linearly in log-log scale)
over all n ranges examined. Error levels of DDA from three
methods were similar to one another. When compared to
logistic regression, the accuracy of DDA was comparable
at larger n and better at smaller n. However, the logis-
tic regression results showed much larger variances (with
respect to different realizations of samples) for small n
than DDA.
In the second setting (Fig. 2c–d), we enlarged the system
to m = 20 SNPs (EE omitted due to computational
costs), and set the parameters such that only 4 SNPs
contributed to disease association. The AUC values were
smaller in comparison to the first setting for smaller
n, which reflects a weaker overall strength of disease
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Fig. 2 Inference accuracy, sensitivity, and specificity of pairwise and collective inference on simulated data. a–b The mean square error and AUC
versus sample sizes using pairwise test (PW), logistic regression (LR), and the three methods of DDA (MF, PL, and EE). Simulated genotypes were
generated for 10 SNPs with parameters h¯y = (−1,−0.3), J¯ = (0, 0.1), σh = σJ = 0.2 (see Methods). c-d Analogous results for 20 SNPs with
h¯y = (−1,−1 + h), J¯ = (0,J), and σh = σJ = 0.2. We set h = 0.7, J = 0.5 for the first 4 SNPs and their interactions and h = J = 0
otherwise. e-f Sensitivity and specificity of disease-associated interaction pairs. Simulated data were generated with parameters h¯ = (−1,−1),
J¯ = (0.01, 0.01), σh = 0.1, σJ = 0.05 form = 10 SNPs, except the interaction between the first two SNPs, for which we set J¯ = (0.01, 0.11).
Interaction p-values for all pairs were calculated either by PW or by regularization to determine λ∗ followed by the construction of null distribution
under λ∗ (Additional file 5: Figure S4) for LR, PL, and EE. The distribution of p-values for the true causal interaction pair and those of non-causal pair
(geometric mean) are shown in e and f, respectively. The dominant model was used in all cases
association, but otherwise showed similar trends. The
accuracy of pairwise tests, logistic regression, and DDA
also exhibited trends similar to simulations in Fig. 2a: both
logistic regression and DDA significantly outperformed
pairwise tests, while DDA consistently showed slightly
better accuracy than logistic regression. The variances
in mean square error were smaller than in the first set-
ting, which suggests that these variances correlate with the
number of causal SNPs. For n = 102, logistic regression
results had a variance much larger than DDA for small n.
These simulations demonstrate that when both
marginal single-SNP and interaction effects are included,
the accuracy of collective inference approach is much
higher than that of pairwise tests. The DDA generally
provides a further edge for smaller sample sizes in
comparison to logistic regression. The comparison of
two different simulation settings in Fig. 2a–b and c–d
demonstrates that this trend is not significantly altered
with increases in the number of SNPs and the fraction of
causal SNPs among them. The accuracy (inferred model
parameters versus true values) remained at similar levels
when the underlying model was changed from dominant
to genotypic models (Additional file 3: Figure S2).
Statistical tests We then examined the performance of
collective inference methods in evaluating the statistical
significance of individual interactions. In GWAS, the sig-
nificance of SNPs and their interactions are tested either
by contingency table or likelihood ratio tests [15]. The
presence of the penalizer λ complicates this approach
in collective inference. In their study of lasso-penalized
logistic regression collective inference, Wu et al. [45]
adopted the approach of first selecting significant SNPs
of a certain size using regularization, and then calculat-
ing p-values of interactions with the penalizer turned off.
A disadvantage of this approach is that the information of
the relative importance of each interactions reflected in
the penalized model is lost when λ is set to zero.
The (analytic) likelihood ratio tests rely on the asymp-
totic distribution of the likelihood ratio statistic q (qi and
qij for a site i and pair i, j): as n → ∞, the distribution of q
under the null hypothesis approaches the χ2-distribution
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with degrees of freedom (d.f.) given by the change in the
number of parameters between the null and alternative
hypotheses [46]. In practice, however, with a finite n, the
deviation from this asymptotic limit can be significant.
We found the null distribution to show increasingly large
deviations from the asymptotic limit as λ increased. We
therefore based our statistical tests in the presence of a
non-vanishing penalizer on empirical null distributions
of qij constructed by permutation resampling (Additional
file 5: Figure S4).
We then sought to evaluate the sensitivity of causal
interaction identification within different inference meth-
ods using simulations. We created simulated data of
m = 10 SNPs, this time with random parameters with
mean values that were identical for both case and control
groups, except a single SNP pair for which the case group
had stronger interactions than the control (Fig. 2e–f). For
collective inference (logistic regression and DDA), we first
performed cross-validation for each sample to determine
optimal λ∗, and then constructed the empirical null dis-
tribution under this λ∗ (Additional file 5: Figure S4) to
calculate p-values of the causal and non-causal interac-
tion pairs (Fig. 2e and f, respectively). We selected the
simulation parameters such that the SNPs were fairly
strongly coupled via LD in each of case and control
groups, but these interaction effects were expected to can-
cel out except for the single causal pair. The pairwise
test results remained insensitive to this causal interac-
tion for all sample sizes. The logistic regression, DDA PL,
and EE methods detected this interaction fairly robustly
for n ≥ 103. In all cases, DDA had higher sensitivity
than logistic regression. The p-values for the non-causal
interactions mostly followed the expected null distribu-
tion qualitatively. However, the distributions from logistic
regression were significantly broader (higher false positive
rates; lower specificity) than DDA for all sample sizes.
In applications to actual disease data, where one aims to
identify statistically significant pairs of interactions based
on p-values, the enhanced sensitivity and specificity of
detection shown in Fig. 2e are of more interest than the
parameter prediction accuracy in Fig. 2a, c. Our results
suggest that the sensitivity of detecting disease-associated
interactions among mostly non-causal SNP pairs from
noisy data is significantly higher with collective inference
than with pairwise tests. The DDA inference furthermore
allowed for consistently higher sensitivity and specificity
than logistic regression.
Age-related macular degeneration
Independent-SNP We first analyzed AMD data under
the independent-SNP assumption and compared the
logistic regression and DDA results. Analytic expressions
are available for the odds ratio and p-values for DDA
[Eqs. (S24), (S27) and (S28) in Additional file 1: Text S1].
Genome-wide p-values derived from DDA (Additional
file 6: Figure S5) were consistent with published results
[41]. The p-values from independent-SNP logistic regres-
sion using PLINK and those from DDA for three main
associated genomic regions (CFH, C2/CFB, and ARMS2
gene groups in chromosomes 1, 6, and 10, respectively)
were the same for most loci except those with strongest
associations, for which p-values from DDA were slightly
smaller (Additional file 7: Figure S6). Differences in p-
values were larger with the genotypic model than with
the dominant model (Additional file 1: Table S1). Thus,
when interactions are not included, DDA gives nearly
the same results as the logistic regression inference. This
feature allows one to directly interrogate how collective
interactions modify association.
Collective inference for 20 SNPs We then examined the
performance of DDA on AMD data under the first mode
of application, where detailed interaction patterns within
a relatively small set of pre-selected SNPs are inferred.
We selected m = 20 AMD SNPs using the variable
selection program GWASelect [47] (see Additional file 1:
Table S1), which covered most regions previously iden-
tified as strongly associated with AMD risks (Additional
file 6: Figure S5 and Additional file 7: Figure S6). The
independent-SNP p-values of this set are shown in Fig. 3c.
For the majority of loci (18 out of 20), the risk allele was
the major allele, and odds ratios were smaller than 1. As
stated above, under this condition of no interaction, the
p-values from logistic regression (from PLINK) and those
from DDA (analytic) were nearly the same.
We applied collective inference (including interactions)
to this 20-SNP set using logistic regression and DDA. We
first performed cross-validation to determine the opti-
mal penalizer λ∗ (Fig. 3a–b). It should be noted that
because the pre-selection of SNPs in this case used
phenotype information of the entire sample, the cross-
validation prediction score is not an unbiased estimate
of the true AUC and is generally higher in value [37]. In
our application, this procedure merely allows for the iden-
tification of optimal regularization levels for collective
inference. We denote the prediction score derived after
such pre-selection using sample phenotypes as pseudo-
AUC (pAUC) in order to distinguish it from the true
estimate of AUC. Unbiased estimates of AUC, if desired,
can be obtained, for example, by performing independent-
SNP p-value-based filtering based only on training sets of
each cross-validation sub-division [37] (see below) or by
using selection criteria unrelated to sample phenotypes
(e.g., pathways).
As observed with the simulated data, when DDA was
used, the pAUC values with varying regularization lev-
els showed a maximum (Fig. 3a–b), which corresponds to
the optimal degree of interaction effects to be included in
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Fig. 3 Collective inference applied to pre-selectedm = 20 AMD SNPs. a–b Regularization via cross-validation. Dominant (DOM) and genotypic
(GEN) models were used with logistic regression (LR), DDA PL (a), and MF (b). Independent-SNP limit is reached with λ → ∞ and  → 0. Because of
the pre-selection of SNPs using phenotype information, the prediction score (pseudo-AUC; pAUC) derived from 5-fold cross-validation
over-estimates the true AUC. The maxima in pAUC correspond to optimal regularization. c–d Single-SNP and interaction p-values of the optimized
(genotypic) model under PL (λ = 0.01). The p-values from independent-SNP and pairwise tests are also shown for comparison in c and d,
respectively. See Additional file 1: Table S1 for the independent-SNP results and SNP list
genotype distributions. For PL (Fig. 3a), the maxima were
located at λ∗ = 0.05 (pAUC = 0.751) and λ∗ = 0.02
(pAUC = 0.765) for the dominant and genotypic models,
respectively. The slightly higher pAUC suggests that for
this data set, the genotypic model provides a better fit. For
DDA, we verified that in the large-λ limit, the inference
outcome approaches the independent-SNP result. The dif-
ference between this limit and the maximum pAUC is
a measure of the relative importance of interactions in
disease association.
We also applied logistic regression-based collective
inference to the same data set. Cross-validation yielded
similar differences between the dominant and genotypic
models (Fig. 3a). However, pAUC did not exhibit pro-
nounced maximum, instead approaching a large-λ limit
nearly monotonically. This limit was slightly higher than
the corresponding DDA maximum, which is consistent
with the expectation that logistic regression can yield
better prediction performance because it maximizes the
prediction score [Eq. (8) in Methods]. On the other hand,
the absence of pronounced maximum in pAUC as a
function of λ indicates a loss in sensitivity in logistic
regression for the detection of interaction effects. This
conclusion can be rationalized in terms of the algorith-
mic difference between logistic regression and DDA: in
DDA, case and control group genotype distributions are
fit separately in terms of their respective single-SNP and
interaction parameters, whereas logistic regression opti-
mizes the prediction score with respect to the net dif-
ferences in those parameters. With more flexibility to
account for differential population structures, DDA has
higher sensitivity to detect interaction effects.
Figure 3b shows the analogous model optimization
under the DDAMF method, where regularization param-
eter values  = 0 and  = 1 each correspond to
independent-SNP and full interaction limits, respectively.
The maximal pAUC values from MF were similar but
slightly lower in comparison to PL. On the other hand,MF
is more computationally efficient that PL and allows for
larger SNP sets.
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We used the optimal penalizer value to determine the
parameters and p-values for this 20-SNP data set under
the genotypic model using DDA PL. The p-values, repre-
senting the statistical significance of the individual terms
included in the model, consist of two classes: single-
SNP and interactions. The single-SNP p-values represent
the significance of marginal single-site effects (associ-
ated with parameters h(y)i or βi). They are analogous
to the independent-SNP p-values of each SNP, but hav-
ing been inferred in the presence of interactions, they
also indirectly reflect interaction effects. Strictly speaking,
the presence of penalizer λ also affects the distribution
of the likelihood ratio statistics qi and it is desirable to
estimate their p-values using permutation resampling.
However, since we did not impose penalty to single-
SNP terms directly [Eq. (4) in Methods], we expect this
effect to be moderate. In practice, these p-values tend
to be much smaller than 1 for SNPs selected based on
independent-SNP properties, and they are difficult to esti-
mate using resampling. We chose to use the asymptotic
χ2-distribution to estimate these single-SNP p-values
under collective inference. These are therefore expected
to be upper-limits (i.e., actual p-values are expected to be
smaller) based on the observation that the penalizer tends
to suppress null distributions to lower q-region.
Figure 3c shows the collective inference single-SNP p-
values of the m = 20 AMD data from DDA. They
largely retained the relative strengths of significance in
independent-SNP results, while in absolute magnitudes
the − log10 p values were mostly reduced. This feature
indicates that in comparison to the independent-SNP
model where single-SNP parameters also contain average
effects of interactions, when collectively inferred, these
terms make reduced contributions to association because
they represent single-site effects only. We also performed
analogous calculations using logistic regression, adopting
the lowest value of penalizer λ = 0.1 at which pAUC
reached the limiting value in Fig. 3a. The single-site p-
values showed larger deviations from the independent-
SNP results (Fig. 3c), with values for many sites becoming
insignificant.
We then performed resamplings of this data set
to obtain interaction p-values (Fig. 3d), which indi-
cated strong interactions within the CFH gene
group in chromosome 1, C2 in chromosome 6,
and ARMS2/HTRA1 group in chromosome 10. In
contrast, pairwise test p-values detected strong inter-
actions only within the last group of loci, between
rs6585827/rs2280141 and rs2014307/rs2248799
(p ∼ 10−9). These short-range interactions suggested by
DDA tended to be correlated with LD: because the net
disease association is related to the difference in SNP
correlation patterns between case and control groups
(Fig. 1), we interpret these short-range interactions as
the consequence of differential LD-patterns in case
and control individuals. The absence of such signals
in pairwise test p-values suggests that such differences
get averaged out when represented only by marginal
SNP-pair distributions.
We sought to further test whether such increased sen-
sitivity toward interactions was achieved with adequate
control for false discovery rates. The selection of m = 20
SNPs in Fig. 3c–d comprises SNPs with highest associ-
ation. For comparison, we made a random selection of
m = 20 SNPs from the genome-wide data and performed
DDA as well as pairwise test. The quantile-quantile plot
(Fig. 4a) showed that p-values for interactions between
these random SNPs were distributed close to the null dis-
tribution. In particular, DDA and pairwise outcomes were
similar, except for one pair for which DDA predicted p ∼
10−3. In contrast, the distribution of interaction p-values
for the highly associated m = 20 SNPs (Fig. 3) from DDA
deviated significantly from the null (Fig. 4b), whereas the
pairwise test outcome remained similar to random SNPs
except for ∼ 10 SNP pairs. These results suggest that
DDA achieves increased sensitivity for interactions while
adequately controlling for false positive rates.
Large-scale collective inference The analysis described
above used a fixed number of pre-selected SNPs
to perform cross-validation and inferences. We next
enlarged the size of SNP sets by controlling it using an
independent-SNP p-value cutoff pc; with the cutoff spec-
ified, in each cross-validation run, the training set was
used to obtain independent-SNP p-values, filter SNPs, and
perform inferences, and the test set was used for pre-
diction. The prediction score derived under this protocol
is an unbiased estimate of the true AUC. The AUC val-
ues (Fig. 5a) showed qualitative trends similar to Fig. 3a;
the AUC maximum relative to the non-interacting limit
was more pronounced, while its height showed a mod-
erate decrease with increasing SNP numbers: inclusion
of less-significant SNPs diluted the overall effects. We
chose a SNP-set size of m = 96 (pc = 10−5 with-
out cross-validation) for interaction pattern analysis. The
interaction p-value computation for m SNPs entails a
multiplication of the single-inference computing time by
m(m − 1)/2 (the number of pairs) times the necessary
random resampling size (∼ 103 or more) for p-value esti-
mation, thus limiting model sizes that can be considered
tom ∼ 100.
The resulting single-site and interaction p-values are
shown in Fig. 6, where the bottom panel compares the
independent-SNP/collective single-site p-values. As in
Fig. 3d for the smaller SNP set, the collective single-
site significance of strongly associated SNPs was gener-
ally reduced in strength compared to the non-interacting
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Fig. 4 Quantile-quantile plot of interaction p-values. a Distributions for interactions amongm = 20 SNPs randomly selected from genome-wide
data. b Distributions for interactions among 20 SNPs with high association (Fig. 3d) and a larger set (m = 96; Fig. 6). See Additional file 8: Figure S7
for pairwise (PW) results form = 96
case. However, rs932275 in chromosome 10 had a com-
parable p-value (strongest within the collective inference
results) and many SNPs originally with weaker associa-
tions in the non-interacting case became stronger under
collective setting. The interaction landscape shown on
the top panel of Fig. 6 retained the qualitative trend
of the results from the smaller data set in Fig. 3d,
but with much more detail; we confirmed the presence
of local interactions within the CFH, C2, and ARMS2
gene groups. In addition, we observed numerous ‘long-
range’ interactions that were absent in the m = 20
results: rs2284664 in CFH interactions with rs511294 and
rs544167 in C2, and there were additional distributed
interactions between the CFH loci and the ARMS2 gene
group. The distribution of interaction p-values was sim-
ilar to that for m = 20 in the quantile-quantile plot
(Fig. 4b). The pairwise test p-value landscape for the
same data (Additional file 8: Figure S7) was also qual-
itatively similar to the m = 20 case (Fig. 3d, bot-
tom).
The overall picture of disease-associated epistatic inter-
actions from our small and larger-scale collective infer-
ences in Figs. 3d and 6 provides a plausible explanation
of the recent observation by Hemani et al. [31], who
detected many epistatic SNP pairs leading to differential
gene expressions within the human genome by exhaus-
tive searches using pairwise tests. Wood et al. [48] then
observed that many of these effects could be explained
Fig. 5 Collective inference with SNP selection based on independent-SNP p-values. a AUC with varying penalizer λ under PL inference, where
independent-SNP p-value cutoff pc indicated was used to filter SNPs from the full genome-wide set in each cross-validation run. The mean SNP
number m¯ is the average over 5 runs. b AUC optimized over regularization (MF) with varying model sizes controlled by pc . SNP selections were
made from the full genome-wide data (r2 < 1.0) and subsets generated by pruning based on LD thresholds indicated. Note that the maximum AUC
position shifts to lower m¯ with increasing degree of pruning (fewer SNPs with LD needed to account for association) and that an optimal level of
pruning (r2 < 0.5) exists for highest performance. Vertical lines are 95 % C.I
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Fig. 6 Interaction and single-site p-values form = 96 AMD SNPs. The bars (bottom) and the heat map (top) show the single-SNP and interaction
p-values, respectively. Hollow and solid bars represent the independent-SNP and collective inference p-values respectively. DDA PL was used for
collective inference
by single untyped third SNPs in LD with the interacting
pairs. Here, we observed both from simulations and AMD
SNP analyses that pairwise tests (Fig. 3d, bottom and
Additional file 8: Figure S7) detect only a subset of statisti-
cally significant interactions, and a portion of the interac-
tion patterns uncovered from collective inference parallels
that of the underlying LD (Fig. 6 and Additional file 9:
Figure S8): SNPs with strong overall correlations often
also have differential LD between case and control groups.
It is thus understandable that interacting pairs of SNPs
identified in marginal pairwise tests turn out to be in LD
with other hidden variants. Our results in Fig. 6, however,
demonstrate a strong presence of interactions beyond
both the population LD (Additional file 9: Figure S8)
and the reach of pairwise tests (Additional file 8:
Figure S7).
Disease-associated epigenomes Most of the disease-
associated loci from GWAS reside in non-coding regions,
presumably exerting their effects through modifications
of gene regulatory action [49]. The overlap of epigenetic
signatures with disease-associated SNPs and their inter-
actions can provide important biological insights to the
underlying disease mechanism. We sought to identify tis-
sue and cell type-specific interaction patterns associated
with AMD phenotypes using the SNP interaction map
we derived above (Fig. 6). We used the recently pub-
lished NIH Roadmap Epigenomics Consortium data [50]
to first calculate the enrichment p-values of the tran-
scribed/enhancer states among the selected 96 AMD
SNPs within each of the 111 reference epigenomes (Fig. 7).
We combined the actively transcribed and enhancer states
of the 15 chromatin state annotations of the reference
epigenomes to define the ‘active’ state. For each AMD-
associated SNP, we identified the group of all known SNPs
that were strongly correlated (high LD), obtained the
distribution of epigenetic states over these SNPs within
a given epigenome, and tested the over-representation
of the active state against the background distribution.
This enlarged search over the set of all known SNPs
in LD with the locus included in inference is crucial to
address the issue of the incomplete coverage of genotype
data.
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Fig. 7 Enrichment p-values of active epigenetic states among AMD-associated SNPs. The set of 96 SNPs in Fig. 6 was used. The reference
epigenome labels are as defined in Fig. 2 of Ref. [50]. ES, embryonic stem cell; ES-deriv., ES cell-derived; HSC, hematopoietic stem cell; iPS, induced
pluripotent stem cell; MSC, mesenchymal stem cell; Neurosph., neurosphere
The most prominent feature in Fig. 7 is the strong
enrichment of active epigenetic states among AMD
SNPs within the liver tissue (E066), followed by ovary
(E097). Two additional epigenomes, embryonic stem cell-
derived neuronal progenitor cultured cells (E009) and
bone marrow-derived mesenchymal stem cells (MSCs;
E026), were also notable, but their enrichment p-values on
the single-SNP level were comparable to other tissues.
We then hypothesized that the statistically significant
interactions between SNPs identified in Fig. 6 would pro-
vide additional information of the cell-type specificity
of epigenetically active states and their interactions. We
selected the SNP pairs with interaction p < 10−3 from
Fig. 6 and, assuming that each groups of LD-correlated
SNPs came from specific cell types (111 × 112/2 possible
pairs, including self-interactions), tested the enrichment
of active state pairs. The p-values derived then reflect
the statistical significance of the epigenetic modifications
enabling the interactions occurring between two cell types
that are disease-associated.
The resulting landscape shown in Fig. 8 exhibited strong
interactions involving the liver tissue, consistent with
the single-SNP result in Fig. 7. However, clear patterns
not seen on the single-SNP level also emerged: bone-
marrow derived MSCs (E026) and adipose nuclei (E063)
also featured prominently in the interaction landscape;
the bulk of interactions involving the liver tissue was
accounted for by those with MSC, adipocytes, and mus-
cle tissues. Embryonic stem cell H1-derived MSCs (E006)
showed interactions that were weaker but similarly dis-
tributed in comparison to bone-marrow derived coun-
terparts. The ovary followed patterns similar to the liver
but was less pronounced than in Fig. 7. In addition, lung
(E096) and placenta (E091) showed some interactions
with adipocytes and MSCs. All of these tissues strongly
interacted with themselves: interacting SNPs in these tis-
sues are highly likely to be active epigenetically.
SNP selection fromgenome-wide data Collective infer-
ence without interaction p-value computation can be
applied to SNP sets of sizes up to m ∼ 104. The predic-
tion AUC as the main outcome for each SNP selection
then allows for the comparison of the relative strengths
of disease association of different SNP groups. In such
applications, the performance of DDA could depend on
(phenotype-independent) processing applied to genome-
wide data in selecting SNP sets for analysis. We evaluated
this secondmode of DDA application and assessed how its
performance varied depending on the degree of LDwithin
SNP sets. We generated different subsets of genome-wide
SNPs by pruning, removing variants that had LD with
neighboring SNPs higher than a threshold (Fig. 5b). The
AUC obtained with SNPs selected from the full genome-
wide data peaked around the mean number of SNPs m¯ ∼
50, as suggested also by Fig. 5a. With LD-based pruning,
the position of maximum shifted to levels up to m¯ ∼ 10,
which suggests that about 10 SNPs in linkage equilibrium
account for the bulk of the association. The height of the
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Fig. 8 Enrichment p-values of active epigenetic state pairs among AMD-associated SNP interactions. The SNP pairs with interaction p-value < 10−3
in Fig. 6 were tested for enrichment within each reference epigenome pairs
AUC first increased with the data pruned with r2 < 0.5
compared to the full set and then decreased with r2 < 0.3,
indicating that there is an optimal level of pruning beyond
which key causal SNPs begin to be removed. Overall, the
relatively small model size ranges where collective infer-
ence performance is maximized in Fig. 5b suggests that
AMD is only weakly polygenic with dominant contribu-
tions from a few loci. Analyses of the type demonstrated
in Fig. 5b thus allows one to assess the polygenicity of
the phenotype under consideration and choose suitable
strategies for SNP selection.
Pathway-based SNP selection An obvious criterion for
grouping genome-wide SNPs into subsets for collective
inference-based evaluation is the proximity to gene sets
belonging to known biological pathways. From the full
AMD genome-wide data, we generated 1,732 SNP sets
corresponding to 1,732 Reactome pathways [51], each
containing from 20 to ∼ 104 SNPs. We then applied DDA
MF inference and derived optimized AUC values for each
pathway (Fig. 9a). The majority of the pathways had asso-
ciation levels [median AUC: 0.514 ± 0.021 (95 % C.I.)]
close to the null value of 0.5. The differences in collec-
tive inference AUC relative to independent-SNP results
ranged from 0 to ∼ 0.06. Reflecting the dominance of
the complement-related genetic loci, Regulation of com-
plement cascade (AUC: 0.688 ± 0.018, m = 448) and
Complement cascade (AUC: 0.684 ± 0.018, m = 869)
showed top association levels clearly separated from the
rest. These AUC values were similar to the levels observed
in pc-based sampling in Fig. 5b adjusted to their corre-
sponding SNP numbers. We used a selection of pathways
with low AUC values to sample their null distributions
and connect AUC (as the statistic for each pathway) and
p-values corresponding to the overall association of each
SNP set (Fig. 9b). The − log10 p values monotonically
increased from 0 as AUC increased from 0.5, and became
highly linear for AUC > 0.52 (r2 = 0.94). We used
this linear regression formula to translate AUC into p-
values. The Bonferroni correction with 1,732 pathways
to the nominal false discovery rate indicated a threshold
of AUC > 0.567, which led to 13 pathways above the
threshold shown in Table 1.
AMD disease mechanism We sought to gain insights
to molecular-level disease mechanisms of AMD by
examining the pathways in Table 1 along with additional
pathways near the threshold and grouping them into
hierarchical classes (Fig. 9c–e). There are two primary
types of AMD, the ‘dry’ and ‘wet’ forms [52]. The dry
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Fig. 9 AMD association of pathways under collective inference. a AUC score versus pathway size (number of SNPs in each pathway). Symbols show
collective and independent-SNP inference AUCs under 5-fold cross validation. Vertical lines are 95 % C.I. The horizontal line represents the
Bonferroni-corrected nominal discovery threshold based on the p-value estimates. b Regression of AUC versus pathway p-values. The latter were
obtained for a selection of pathways via phenotype-label reshuffling using AUC as the statistic. Dotted line is the linear fit for AUC > 0.52. c–e
Pathways with association strength AUC > 0.55, grouped according to the top hierarchical classes they belong to. We excluded pathways in the
Disease class. Dendrograms below the bars show their hierarchical relationships. Abl, Abl tyrosine kinase; activ., activation; assoc.,
association/associated; biosynth., biosynthesis; C3, complement component 3; C5, complement component 5; CCT, chaperonin-containing
T-complex polypeptide 1; cell., cellular; ChREBP, carbohydrate response element-binding protein; ECM, extracellular matrix; EHMT2, euchromatic
histone-lysine-methyltransferase 2; elong., elongation; ER, endoplasmic reticulum; ERCC6, excision repair cross-complementation group 6; expr.,
expression; form., formation; HSF, heat shock factor; IFN, interferon; indep., independent; Lys, lysine; MDA5, melanoma differentiation-associated
gene 5; med., mediated; metab., metabolism; MYD88, myeloid differentiation primary response 88; NFKB, nuclear factor-κ B; PA, phosphatidic acid;
PKMT, protein lysine methyltransferase; pol, polymerase; proc., processing; reg., regulate/regulation/regulated; RIG-I, retinoic acid-inducible gene-I;
RIP, receptor-interaction protein; Robo, roundabout; SASP, senescence-associated secretory phenotype; sig., signaling; SMAC, second mitochondrial
activator of caspases; synth., synthesis; sys., system; thru, through; TP53, tumor protein p53; transc., transcription/transcriptional; TriC, T-complex
polypeptide 1 ring complex; ZBP1, Z-DNA-binding protein-1
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Table 1 Pathways highly associated with AMD in collective inference
Rank Pathway No. of SNPs AUCa p-valueb
1 Regulation of complement cascade 448 0.688 (0.018) 9 × 10−16
2 Complement cascade 869 0.684 (0.018) 2 × 10−15
3 Innate immune system 14,406 0.627 (0.019) 2 × 10−10
4 Immune system 25,770 0.601 (0.020) 3 × 10−8
5 Activation of C3 and C5 147 0.587 (0.020) 5 × 10−7
6 Initial triggering of complement 522 0.584 (0.020) 1 × 10−6
7 Alternative complement activation 118 0.581 (0.020) 2 × 10−6
8 Regulation of TP53 activity through methylation 322 0.581 (0.020) 2 × 10−6
9 Synthesis of phosphatidic acid 559 0.575 (0.020) 7 × 10−6
10 Glycerophospholipid biosynthesis 1,969 0.571 (0.020) 1 × 10−5
11 Protein folding 1,777 0.570 (0.020) 2 × 10−5
12 Chaperonin-mediated protein folding 1,661 0.570 (0.020) 2 × 10−5
13 Degradation of extracellular matrix 2,324 0.570 (0.020) 2 × 10−5
a95 % C.I. in parentheses
bEstimated from the regression in Fig. 9b
C3, complement component 3
C5, complement component 5
TP53, tumor protein p53
AMDmore commonly occurs in earlier stages, where reti-
nal pigment epithelium (RPE) cells supporting photore-
ceptors in the retina undergo degeneration, often accom-
panied by the accumulation of drusen in the area between
RPE and the Bruch’s membrane separating the retina from
the choroid. The wet AMD is characterized by invasive
choroidal neovascularization of the retina. In both forms,
cellular stress factors exacerbated by aging are the pri-
mary causes leading to RPE dysfunction. The normal
functioning of photoreceptors, bombarded by light and
highly susceptible to oxidative damage, relies on continual
recycling of their spent outer segments via phagocytosis
by RPE cells [53]. Peroxidation products of phospho-
lipids, the key ingredients of photoreceptors, often end
up as major components of drusen, and serve as damage-
associated molecular patterns activating innate immune
receptors, including toll-like receptors (TLRs) as well as
complement factor H (CFH) [54]. The latter has been
shown to bind malondialdehyde (MDA) derived from
docosahexaenoic acid [55]. In addition, phosphatidylser-
ine is the main ‘eat-me’ signal toward phagocytes when
displayed on the extracellular membrane of dying cells
[56]. Consistent with these aspects of AMD pathogene-
sis, we found associations with Phospholipid metabolism
pathways (Fig. 9e), and in particular, Synthesis of phos-
phatidic acid, which suggests that disease risk is affected
by genetic variants modifying the ability to supply these
phospholipids.
Phospholipid synthesis requires the supply of fatty acids,
synthesized in the liver. The causal link to this process
of lipogenesis is suggested in Fig. 9e by the pathway
Carbohydrate response element-binding protein (ChREBP)
activates metabolic gene expression. ChREBP is a key tran-
scription factor in hepatocytes, responding to glucose
uptake and activating genes involved in lipogenesis [57,
58]. Fatty acids thus synthesized are transported into the
bloodstream in the form of very low density lipoproteins
and stored as triacylglycerols in adipocytes [57]. The sug-
gested AMD risk association of the fatty acid supply from
the liver and adipocytes for phospholipid synthesis pro-
vides an explanation of our earlier finding in Fig. 8 that
SNP interactions associated with AMD are epigenetically
active in the liver and adipocytes.
Oxidative stress is often accompanied by disruptions
to protein folding, which can lead to protein aggrega-
tion and autophagy when refolding by chaperones proves
inadequate [59]. We found association in Protein folding
pathways (Fig. 9e), and in particularChaperonin-mediated
protein folding, which primarily targets actins and tubu-
lins, the major ingredients of cytoskeletal networks [60].
This observation suggests that RPE stress from protein
misfolding affects AMD risk via its effect on phagocytic
function, which relies heavily on actin filament andmicro-
tubule remodeling dynamics [56]. Also closely related
is the Regulation of heat shock factor (HSF) 1-mediated
heat shock response in Fig. 9e, which describes the tran-
scriptional activation of heat shock protein (chaperone)
expression under stress. The latter pathway belongs to
the Cellular responses to stress group, in which we also
found association with Senescence-associated secretory
phenotype (SASP). Senescence is one of the possible fates
of cells under stress, where normal cellular growth is
arrested in preparation for clearance by phagocytes [61].
SASP refers to a complex suite of inflammatory cytokines,
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chemokines, and growth factors facilitating the process,
and we infer that senescence in RPE cells under oxidative
stress plays a part in AMD.
Apoptosis, or controlled cell death [62], is anothermajor
stressed-cell response, and was also represented in our
results (Fig. 9e). A large body of direct evidence points
to apoptosis as one of the main routes of RPE degener-
ation in AMD [63]. Induction of apoptosis upon stress
is dictated by the action of master regulator p53, and it
was recently shown that aging increases the activity of p53
in RPE cells and the likelihood for apoptotic cell death
[64]. Consistent with this evidence, we found associa-
tion with pathways in Transcriptional regulation by TP53
group (Fig. 9d). In particular, Regulation of TP53 activity
through methylation was among the top pathway in our
association analysis (Table 1), suggesting that p53 mod-
ification by methylation and the closely related histone
modifications [Protein lysine methyltransferases (PKMTs)
methylate histone lysine in Fig. 9e] play important roles
in RPE apoptosis regulation. In the intrinsic apoptotic
pathway induced by oxidative stress, cytochrome c is
released from mitochondria into the cytosol, binding and
activating caspases, the main proteases central to apop-
totic action. We found association in pathways involving
‘inhibitor of apoptosis’ (IAP) and its negative regulator
‘secondmitochondrial activator of caspases’ (SMAC) [65],
which suggests that disruption to regulatory mechanisms
preventing apoptosis in RPE cells may play roles in AMD.
RPE degeneration and drusen formation can lead to
inflammation, the main innate immune response involv-
ing a wide range of pattern-recognition receptors (PRRs)
and complement activation [66]. Most of known PRRs
were represented in our results (Fig. 9c), including TLRs,
advanced glycosylation endproduct receptors, RIG-I-like
receptors, and cytosolic DNA sensors [66]. Complement
factors constitute the soluble counterparts of PRRs, and
Regulation of complement cascade showed the highest
association due to the contribution of CFH, as well as
Activation of C3 and C5. CFH normally protects self tis-
sues from complement-induced destruction by binding
to a range of surface signals including glycoproteins and
C-reactive protein. In addition to the binding of CFH
to MDA noted above, it was also reported that CFH
inhibits lipoprotein binding toward Bruch’s membrane
[67]. The breach of Bruch’s membrane and the intrusion
of blood vessels into the retina are the hallmarks of wet
AMD [52], which are consistent with our finding of high
association in Degradation of extracellular matrix and
Common pathway of fibrin clot formation in Fig. 9e.
Conclusions
In this paper, we first described and tested discrimi-
nant analysis-based algorithms inferring collective dis-
ease association effects applied to intermediate-sized SNP
sets. Using simulated and actual disease data, we pro-
vided evidence suggesting that collective inference meth-
ods outperform pairwise tests and logistic regression in
incorporating interaction effects in disease association.
We demonstrated two different modes of applying DDA
in the analysis of actual disease data: one in which detailed
interaction patterns within a relatively small set of SNPs
are inferred, and the other where genome-wide SNP data
are grouped into different subsets of SNPs and collec-
tive inference is used to compute the degrees of dis-
ease association of each subset. Our results applied to
AMD in Fig. 9 based on pathway-based SNP selection,
in particular, show that the latter protocol allows us to
identify pathways encompassing a large fraction of dis-
ease mechanisms previously established by non-genetic
means. Based on current study, we propose the follow-
ing approach to deal with novel GWAS case-control data
using DDA: first, characterize the degree of polygenicity
of the data set with independent-SNP and collective infer-
ences employing pc-based SNP selection and optimize the
density of SNPs using LD-based pruning (Fig. 5). Sec-
ond, classify SNPs into pathway-based groups, score them
using collective inference, and seek insights to the under-
lying disease mechanisms by analyzing the results within
the pathway hierarchy.
Methods
Genotype distribution of case-control groups
Our algorithm is best understood in comparison to
the classical continuous variable discriminant analysis.
Table 2 outlines the similarities and differences of classical
(continuous variable) and discrete (our adaptation) ver-
sions of discriminant analyses. In the continuous variable
case, one aims to classify data into two known groups, case
and control (denoted by y = 1 and y = 0, respectively),
based on predictor a, a vector of dimension m. Classifi-
cation (and inference) are performed by maximizing the
likelihood of model parameters given the training data of
known class identities, i.e., the joint probability
Pr(a, y) = Pr(a|y)py, (1)
where py is the marginal probability of group mem-
bership. One then finds the class-specific mean vectors
μy and covariance matrices 	y. These quantities define
the predictor distribution within each class, which are






y a − at	−1y a/2
)
, (2)
where the superscript t denotes transpose. In this formu-
lation, the maximum likelihood condition for Eq. (1) is
equivalent to maximizing the discriminant function δy(a)
given by the exponent of Eq. (2) plus ln py, which is used
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Table 2 Comparison of continuous-variable/discrete discriminant analyses
Predictor, a Classes Parameters Predictor distribution for class y Prediction
Continuous variables Case (y = 1) μ1, 	1 N(μy ,	y) Decision boundary:
Control (y = 0) μ0, 	0 δ0(a) = δ1(a)
Discrete variables Case (y = 1) ψ1 = {h(1)i , J(1)ij } Pr(a;ψy|y) βi = h(1)i − h(0)i
Control (y = 0) ψ0 = {h(0)i , J(0)ij } given by Eq. (3) γij = J(1)ij − J(0)ij
to classify an arbitrary data a into case if δ1(a) > δ0(a) and
control otherwise [37]. It is also useful to note that if we
assume that a is a scalar, this framework reduces to t-tests
for the null hypothesis μ0 = μ1.
For our application, the predictor a is the collection of
genotypes, which is discrete. The description here applies
to the binary model (dominant or recessive), such that
ai = 0, 1 represent aa and Aa/AA for SNP i for the
dominant model, and aa/Aa and AA for the recessive
model (see Additional file 1: Text S1 for the genotypic
model). Figure 1 illustrates the general spirit of the DDA
algorithm. Training data of known phenotypes can be
used to obtain allele frequency vectors and covariance
matrices with elements fˆ (y)i and fˆ
(y)
ij , respectively, where
i, j = 1, · · · ,m are SNP indices. Note that these quanti-
ties are the exact counterparts of the continuous variable
mean μy and covariance 	y. We model the genotype












where h(y)i and J
(y)
ij are model parameters of the distri-
bution that we refer to as single-SNP and interaction
parameters, respectively. Comparing Eqs. (2) and (3), one
can observe that these parameters ψy ≡ {h(y)i , J(y)ij }, each
multiplying predictor a in linear and quadratic fashion,
respectively, are expected to be related to frequencies
fˆ (y)i and fˆ
(y)
ij . In contrast to the continuous case, how-
ever, the exact form of this relationship is unknown due
to the discrete nature of a, except for the special case of
independent SNPs (see Section S1.5 in Additional file 1:
Text S1; we refer to the special case of no interaction as the
independent-SNP case).
The inference of this relationship is the major compu-
tational component of DDA, and is based on maximizing















where the first summation is over genotype data of ny
individuals in group y, and λ denotes a regularization
parameter (penalizer) that controls the contribution of the
SNP interactions in comparison to the independent-SNP
case. The independent-SNP limit is reached with λ → ∞,
where optimal values of J(y)ij all become zero due to high
penalty. We opted for an l2-penalizer rather than l1; the
latter generally exerts stronger effects [69] but l2 is ana-
lytic and facilitates non-linear optimization. In Additional
file 1: Text S1, we show implementations of three possible
ways to perform this inference of varying computational
cost and reliability: exact enumeration (EE), mean field
(MF) [68], and pseudo-likelihood (PL) [70, 71] methods.
The EE is essentially exact, but requires enumerations of
all possible genotypes, and can only be used for m ∼ 25
or less. We used this option to assess the reliability of
the other two methods. Both MF and PL are approximate
and can be used for m ∼ 103 or larger. The MF option
involves matrix inversion and requires a different regu-
larization: instead of λ, we used  ∈[0, 1], where  = 0
corresponds to the independent-SNP limit with no inter-
action. The PL method uses λ > 0 and has the advantage
that it can be easily parallelized. We implemented parallel
computations of PL using the message passing interface
protocol.
Disease risk
Once genotype distributions of case, control, and pooled
(whole sample) groups have been inferred, Bayes’ theorem
allows one to obtain disease risk:
Pr(y=1|a)= Pr (a|y = 1) p1∑









One can show that (Additional file 1: Text S1)
βi = h(1)i − h(0)i , (6a)
γij = J(1)ij − J(0)ij . (6b)
In other words, the single-SNP and interaction disease risk
parameters θ = {βi, γij} are given by differences in geno-
type distribution parameters between case and control
groups. In addition, the overall likelihood ratio statistic is
given by the sum of Ly subtracted by the pooled value (see
Fig. 1). The parameter α is related to disease prevalence
p1 = 1 − p0 (see Additional file 1: Text S1).
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We used cross-validation to determine the penalizer λ
in Eq. (4). We first formed five training and test sets (of 4:1
size ratios) from the data and used the training set to select
variants with independent SNP p-values below a cutoff.
We calculated the AUC for different λ values and found
an optimal choice. Even when the actual AUC values
obtained are not high enough for a reasonable risk pre-
diction, this procedure still allows us to identify optimal
ranges of the model size (the role of interactions).
We used disease prevalence p1 = n1/n for cross-
validation because the training and test sets have the
same sampling biases. In predicting risks with a prospec-
tive sample, however, this probability would have to be
adjusted to known population phenotype frequencies. We
implemented a software feature such that the disease
prevalence, which affects the disease risk parameter α,
can be re-specified when a parameter set inferred from
case-control data is applied to an independent test set.
Logistic regression









instead of Eq. (1), assuming that the marginal genotype
distribution is uniform. The parameters α,βi, and γij are












γ 2ij , (8)
where n = n0 + n1, with respect to α, βi, and γij. In
general, these disease risk parameter values from logistic
regression are different from those obtained via genotype
distribution parameters ψy in DDA with Eq. (6); the latter
contains the effects of the nonuniform marginal genotype
distribution Pr(a) of the sample, while logistic regres-
sion does not. For comparison, we also implemented this
multivariate logistic regression with an l2-penalizer. The
logistic regression can yield higher prediction AUC than
DDA because by maximizing Eq. (8), one optimizes pre-
diction directly. However, the quantity maximized in DDA
given by Eq. (4) (or in fact the sum L0 + L1; see Additional
file 1: Text S1), rather than the prediction score, is the true
likelihood.
Significance tests
We performed likelihood ratio tests to assess the statis-
tical significance of the overall collective inference and
individual loci/interactions. The p-values derived are con-
ditional to the number of loci m and penalizer value
λ (determined from cross-validation). The statistic was
obtained by adding the log-likelihood values of case and
control groups and subtracting that of the pooled group
(see Text S1).We tested the significance of the single-locus
contribution to disease association from site i by calcu-
lating the likelihoods Ly[h(y)i = hi], where the single-SNP
parameters of site i were prescribed as their pooled values
(restricted model), and evaluating the differences against
the likelihood of the full model (all parameters optimized
without restriction). Analogous tests were performed for
SNP pair i, jwith Ly[J(y)ij = Jij]. The restrictedmodel corre-
sponds to the null hypothesis that the parameters belong-
ing to a particular locus or interaction in case and control
groups are the same as for those in the pooled group. For
interaction statistics, we used the approach of construct-
ing the empirical null distribution of the statistics under a
given λ by permutation resampling: the phenotype data of
a given sample with a certain penalizer λ value was ran-
domly reshuffled to obtain realizations of the likelihood
ratio statistics. This sampling was repeated multiple times
(up to ∼ 104) to construct empirical cumulative distribu-
tion functions of the statistic for each site, or SNP-pair,
from which the p-values were estimated. For the single-
locus contribution statistics, we calculated p-values using
the asymptotic χ2-distribution.
Simulation
In testing the inference algorithms using simulated data,
samples of case-control genotypes containing m = 10
or 20 loci and n = 2n0 individuals were generated
under randomly assigned parameters {ψ0,ψ1}. The model
parameters were chosen with h(y)i ∼ N(h¯y, σ 2h ), and
J(y)ij ∼ N(J¯y, σ 2J ). To generate simulated data from these
distributions, we evaluated summations over all (2m for
binary models) possible genotypes to calculate their prob-
ability distribution using Eq. (3). For a given sample,
cross-validation was first performed with λ values rang-
ing from 10−4 to 102 to determine the optimal value
λ∗ that maximizes AUC. The parameters θ were then
derived using the full sample and λ∗. For DDA, the
single-SNP and interaction parameters for case and con-
trol groups (ψ0 and ψ1, respectively) were obtained and
used to derive θ . In contrast, in logistic regression, θ
was obtained directly. The mean square error was calcu-
lated for inferred θ relative to true values of all distinct
single-SNP and interaction parameters. We performed
different inferences using a common set of data for each
realization of parameters. The mean square error was
then averaged over 100 realizations of parameters. We
also compared pairwise test results using PLINK [44]
epistasis module. We used PLINK version 1.9 with logis-
tic regression and either dominant or genotypic coding
options.
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Age-related macular degeneration data
We obtained AMD case-control genotype data from the
National Eye Institute Study of AMD Database (dbGaP
accession number phs000684.v1.p1), which consisted of
2,159 case and 1,150 control individuals. Autosomal SNPs
were filtered with the criteria of MAF > 0.01, Hardy-
Weinberg equilibrium p-value > 10−6, and genotyp-
ing rate > 0.05 [41] to yield 324,713 SNPs in total.
Independent-SNP DDA analyses were performed using
Eq. (S24) and (S27) in Additional file 1: Text S1 and
compared with logistic regression results from PLINK
[44] in addition to our numerical logistic regression
implementation. For each SNP, the minor allele was
identified from the allele frequencies over the pooled
sample.
Except otherwise stated, inferences on AMD data used
the genotypic model. In all cases, λ (or  for MF) was
first determined from cross-validation (optimal value λ∗
with the maximum AUC) and later used consistently for
parameter estimation and p-value calculation. Interaction
p-values were obtained for a given SNP selection and λ∗
by resampling.
To generate SNP sets with reduced LD for pc-based
selection (Fig. 5b), we used the pairwise LD-based prun-
ing option of PLINKwith window size of 50 kb and 5 SNPs
for shifts along with r2-thresholds of 0.5 and 0.3. The two
threshold choices yielded SNP sets with m =180,354 and
117,976, respectively.
In performing the epigenetic state enrichment analysis,
for each SNP considered, we used the 1000 Genomes ref-
erence haplotypes [72] of European individuals to build
the list of correlated SNPs (LD r2 > 0.5). We then
used the NIH Roadmap reference epigenome chromatin
state annotations [50] to construct the distribution of
epigenetic states within each group of LD-correlated
SNPs. We used the hidden Markov model-based 15
state-annotations of 111 reference epigenomes, selecting
8 states [active transcription start site (TSS), flanking
active TSS, transcription at gene 5’ and 3’, strong tran-
scription, weak transcription, zinc finger-associated, genic
enhancers, and enhancers] to define the ‘active’ state,
which contained the transcribed, promoter, and enhancer
regions. For each SNP location, we calculated the frac-
tion of LD-correlated locations in active states within
each cell type. This fraction was summed over the list of
associated SNPs (m = 96 in Fig. 7) to give the effec-
tive number of active states observed, and compared
with the background active state frequency estimated
over the whole genome for each epigenome. The over-
representation p-values were calculated by the binomial
test.
Analogous calculations were performed for the SNP
interaction enrichment analysis. We first selected statisti-
cally significant SNP pairs with p < 10−3 from Fig. 6 (310
in total). We then considered each unique combination of
two epigenomes (including self-interactions) and, for each
SNP pair selected, obtained the fraction of active state-
active state pairs with the two groups of LD-correlated
SNPs assumed to belong to the two epigenomes. This frac-
tion was summed over the list of SNP pairs and compared
with the background expected pair number (product of
background active state frequencies from two tissues).
Over-representation p-values were calculated using the
binomial test.
Pathway-based SNP sets were generated for human
pathways in Reactome database [51]. We compiled the
list of all genes, assigned SNPs in the AMD genome-wide
set within 50 kb of the coding region to each gene, and
collected SNPs corresponding to the gene set belonging
to each pathway. Only those pathways with 20 or more
SNPs were considered (1,732 in total). For most pathways
with m < 6 × 103, DDA independent-SNP and collec-
tive inference (-optimized MF) inferences were applied
to each SNP set without further filtering to derive 5-fold
cross-validation AUC. For larger pathways, pc-based fil-
tering was incorporated into cross-validation to reduce
the model sizes.
Additional files
Additional file 1: Supplementary material. Text S1.Mathematical
formulation of inference algorithms. Table S1. Independent-SNP inference
comparison of logistic regression (from PLINK) and DDA (GeDI). (PDF 283 kb)
Additional file 2: Figure S1. Inference properties of a single independent
SNP. Log odds ratio (OR) and power (level of significance 0.05) inferred from
case-control data of size n = 2n0 = 2n1 using DDA (analytic) and logistic
regression (numerical) are shown for the dominant model. Equation (S29)
of Text S1 was used. The minor allele frequency φy for control and case
groups were set such that f (y) = 2φy(1− φy) + φ2y = φy(2− φy). We used
φy = (0.1, 0.25) such that f (y) = (0.19, 0.4375) and h(y) = (−1.45,−0.25)
for control and case groups, respectively, and β = 1.1987. (PDF 6.99 kb)
Additional file 3: Figure S2. Examples of true versus inferred parameters.
a Dominant model withm = 10 SNPs and inference on a sample of size
n = 103. b Genotypic model withm = 10 SNPs and inference on a sample
of size n = 105. In all cases, the penalizer value was determined by
cross-validation. (PDF 18.1 kb)
Additional file 4: Figure S3. Determination of penalizer λ via
cross-validation. The data set is one realization of simulations shown in
Fig. 2b and the inference is with the exact enumeration (EE) method. The
minima in mean square error (a) and the maxima in AUC (b) shift to lower λ
as sample size n increases. (PDF 6.17 kb)
Additional file 5: Figure S4. Distributions of interaction likelihood ratio
statistics under the null hypothesis. Empirical cumulative distribution
functions (CDF) in terms of the interaction statistics q were obtained by
resampling. Simulation conditions were as described in Fig. 2e and
inferences used EE. (PDF 7.39 kb)
Additional file 6: Figure S5.Whole-genome p-value profile of AMD data.
Independent-SNP DDA with genotypic model was used. (PDF 25.7 kb)
Additional file 7: Figure S6. Regional views of AMD data.
Independent-SNP DDA results (light blue) are compared to logistic
regression from PLINK (yellow). Genotypic model was used. (PDF 10.9 kb)
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Additional file 8: Figure S7.Marginal pairwise interaction p-values.
PLINK epistatic module was used tom = 96 AMD SNPs. SNP pairs with
strongest p-values near HTRA1 have p ∼ 10−9. Genotypic model was used.
The bottom panel shows the independent-SNP p-values. (PDF 54.6 kb)
Additional file 9: Figure S8. Linkage disequilibrium r2 withinm = 96
AMD SNPs from PLINK. (PDF 48.3 kb)
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